Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sutro Biopharma (STRO) Debt Ratio (2017 - 2023)

Historic Debt Ratio for Sutro Biopharma (STRO) over the last 7 years, with Q4 2023 value amounting to 0.01.

  • Sutro Biopharma's Debt Ratio fell 7842.37% to 0.01 in Q4 2023 from the same period last year, while for Dec 2023 it was 0.01, marking a year-over-year decrease of 7842.37%. This contributed to the annual value of 0.01 for FY2023, which is 7842.37% down from last year.
  • As of Q4 2023, Sutro Biopharma's Debt Ratio stood at 0.01, which was down 7842.37% from 0.02 recorded in Q3 2023.
  • In the past 5 years, Sutro Biopharma's Debt Ratio registered a high of 0.16 during Q1 2020, and its lowest value of 0.01 during Q4 2023.
  • In the last 5 years, Sutro Biopharma's Debt Ratio had a median value of 0.07 in 2019 and averaged 0.06.
  • As far as peak fluctuations go, Sutro Biopharma's Debt Ratio surged by 12277.77% in 2020, and later plummeted by 7842.37% in 2023.
  • Quarter analysis of 5 years shows Sutro Biopharma's Debt Ratio stood at 0.06 in 2019, then dropped by 1.39% to 0.06 in 2020, then grew by 18.11% to 0.07 in 2021, then plummeted by 45.64% to 0.04 in 2022, then plummeted by 78.42% to 0.01 in 2023.
  • Its Debt Ratio was 0.01 in Q4 2023, compared to 0.02 in Q3 2023 and 0.02 in Q2 2023.